IndiaOne Finance - Company Dashboard

Governance Classic Home

Marksans Pharma LtdPharmaceuticalsINE750C01026Consolidated₹319.80+0.65 (+0.20%)Jun-26

Valuation

Market Cap₹14.51K Cr

TTM PE28.06x

Forward PE25.99x

PEG1.19

Book Value₹66.71

P/B4.80x

TTM EPS₹11.41

Fwd EPS₹12.32

TTM Revenue₹3.17K Cr

TTM PAT₹521.27 Cr

TTM EBITDA₹713.70 Cr

TTM EBIT₹613.30 Cr

Last Qtr PAT₹159.41 Cr

Last Qtr EBITDA₹213.03 Cr

Last Qtr EBIT₹188.17 Cr

Profitability

ROE17.24%

ROCE21.26%

TTM NPM16.43%

TTM EBITDA %22.50%

Curr OPM18.40%

Last OPM16.72%

Curr NPM—

Last NPM—

Curr EPS₹3.47

Last EPS₹3.27

Balance sheet

Equity₹45.32 Cr

Reserve₹2.98K Cr

Total Debt₹343.38 Cr

D/E0.11x

Interest %4.39%

Curr Interest₹7.00 Cr

Price / range

Close₹320.15

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.14%

1W-2.59%

1M-1.99%

3M+22.39%

6M+90.41%

1Y+79.51%

2Y+13.83%

3Y+215.26%

5Y+349.96%

Diwali+78.11%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	321.19+0.5%	361.57	339.73	320.44	319.73	1,341.48
Other Income	17.47	27.48	15.86	58.19	2.01	103.53
Total Income	338.66+5.3%	389.05	355.59	378.63	321.74	1,445.01
Interest	0.34	0.35	0.36	0.32	0.30	1.33
Expenditure	-248.20+3.9%	-264.69	-273.47	-257.14	-258.17	-1,053.47
PBDT	0	0	0	0	0	0
EBITDA	82.11+17.2%	105.99	75.45	72.08	70.05	323.57
Depreciation	-8.78	-8.76	-8.83	-8.46	-8.19	-34.23
EBIT	73.33+18.5%	97.23	66.62	63.62	61.86	289.34
PBT	90.46+42.3%	124.36	82.12	121.49	63.57	391.54
Tax	-21.42	-32.44	-21.20	-21.69	-15.52	-90.85
Equity	45.32	45.32	45.32	0	45.32	45.32
OPM	26.71	31.97	23.09	37.91	19.76	27.10
Net Profit	69.04+43.7%	91.92	60.91	99.81	48.06	300.70
NPM	20.39	23.63	17.13	31.15	14.94	20.81
EPS	1.52+43.4%	2.03	1.34	2.20	1.06	6.64

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,341.48+14.2%	1,174.37+37.6%	853.27+30.2%	655.20-0.5%	658.29+9.8%	599.55
Other Income	103.53	69.83	62.07	60.48	42.25	31.16
Total Income	1,445.01+16.1%	1,244.21+35.9%	915.35+27.9%	715.69+2.2%	700.54+11.1%	630.70
Expenditure	-1,053.47-5.2%	-1,000.95-34.6%	-743.45-27.4%	-583.65-3.1%	-566.03-11.8%	-506.37
Interest	-1.33	-1.17	-0.99	-3.61	-3.80	-5.35
PBDT	0	0	0	0	0	0
EBITDA	323.57+58.6%	204.04+45.8%	139.94+52.3%	91.90-19.2%	113.72+0.0%	113.72
Depreciation	-34.23	-29.45	-29.13	-16.74	-17.66	-15.19
EBIT	289.34+65.7%	174.59+57.6%	110.81+47.4%	75.16-21.8%	96.06-2.5%	98.53
PBT	391.54+61.0%	243.26+41.5%	171.89+30.2%	132.04-1.8%	134.51+8.2%	124.33
Tax	-90.85	-54.99	-38.13	-29.17	-30.52	-25.95
Equity	45.32	45.32	0	0	0	0
OPM (%)	27.10	19.55	19.00	18.00	19.00	20.00
Net Profit	300.70+59.7%	188.27+40.8%	133.76+30.0%	102.87-1.1%	103.99+5.7%	98.38
NPM (%)	20.81	15.13	15.00	14.00	15.00	16.00
EPS (Rs)	6.64+60.0%	4.15+40.7%	2.95+19.0%	2.48-2.4%	2.54+5.8%	2.40
CEPS	6.63	4.15	2.95	2.48	2.54	2.40

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	840.80+35.6%	856.11	754.43	720.41	619.99	2,950.94
Other Income	25.40	35.17	20.14	21.57	5.64	82.53
Total Income	866.20+38.5%	891.29	774.57	741.98	625.63	3,033.47
Interest	7	6.31	5.94	5.82	6.07	24.13
Expenditure	-659.63-20.1%	-691.29	-623.95	-608.65	-549.03	-2,472.92
PBDT	0	0	0	0	0	0
EBITDA	213.03+112.8%	195.42	160.75	144.50	100.13	600.78
Depreciation	-24.86	-24.29	-24.33	-26.92	-23.10	-98.63
EBIT	188.17+144.3%	171.13	136.42	117.58	77.03	502.15
PBT	206.57+169.7%	200	150.62	133.33	76.60	560.56
Tax	-47.16	-50.97	-36.93	-34.20	-18.40	-140.49
Equity	45.32	45.32	0	0	45.32	45.32
OPM	23.85	22.44	19.45	17.97	12.24	18.48
Net Profit	159.41+173.9%	149.03	113.69	99.14	58.20	420.06
NPM	18.40	16.72	14.68	13.36	9.30	13.85
EPS	3.47+169.0%	3.27	2.50	2.17	1.29	9.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	2,950.94+1025.1%	262.28-88.0%	2,177.41+17.6%	1,852.14+24.2%	1,490.84+8.3%	1,376.18
Other Income	82.53	7.04	50.42	59.31	41.85	6.69
Total Income	3,033.47+1026.3%	269.32-87.9%	2,227.83+16.6%	1,911.45+24.7%	1,532.69+10.8%	1,382.88
Expenditure	-2,472.92-1029.5%	-218.93+87.9%	-1,804.30-14.6%	-1,573.80-22.5%	-1,285.18-18.9%	-1,080.71
Interest	-24.13	-1.17	-11.20	-9.13	-8.45	-7.99
PBDT	0	0	0	0	0	0
EBITDA	600.78+1036.5%	52.86-88.5%	458.58+35.1%	339.32+31.1%	258.89-23.8%	339.61
Depreciation	-98.63	-8.34	-74.27	-51.85	-44.78	-36.15
EBIT	502.15+1027.9%	44.52-88.4%	384.31+33.7%	287.47+34.3%	214.11-29.4%	303.46
PBT	560.56+1012.2%	50.40-88.1%	423.53+25.4%	337.65+36.4%	247.51-18.1%	302.16
Tax	-140.49	-12.13	-108.63	-72.33	-60.70	-63.63
Equity	45.32	4.53	0	0	0	0
OPM (%)	18.48	18.71	19.01	17.66	16.15	21.85
Net Profit	420.06+997.9%	38.26-87.9%	314.90+18.7%	265.32+42.0%	186.81-21.7%	238.54
NPM (%)	13.85	14.21	14.13	13.88	12.19	17.25
EPS (Rs)	9.22+9.8%	8.40+21.4%	6.92+8.0%	6.41+42.1%	4.51-21.7%	5.76
CEPS	9.22	8.40	6.92	6.41	4.51	5.76

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.9	20 Aug 2026
2025	Final Dividend	0.8	01 Aug 2025
2024	Final Dividend	0.6	17 Sep 2024
2023	Final Dividend	0.5	07 Jun 2023
2022	Final Dividend	0.25	19 Aug 2022
2021	Final Dividend	0.25	15 Sep 2021
2020	Final Dividend	0.1	22 Sep 2020
2019	Final Dividend	0.05	19 Sep 2019
2018	Final Dividend	0.05	19 Sep 2018
2017	Final Dividend	0.05	19 Sep 2017
2016	Final Dividend	0.12	22 Sep 2016
2015	Final Dividend	0.12	23 Sep 2015
2014	Final Dividend	0.1	18 Sep 2014

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split